Auriga reiterates a 'Buy' on MedAssets (Nasdaq: MDAS), raises price target to $24 from $20.

Auriga analyst says, "We still ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE